Skip to main content
. Author manuscript; available in PMC: 2015 Mar 5.
Published in final edited form as: J Alzheimers Dis. 2015;43(3):1007–1016. doi: 10.3233/JAD-141287

Fig. 1.

Fig. 1

CSF α-synuclein and hallucinations. CSF α-synuclein (logarithmized, centered, and scaled) in people with or without a medical history of hallucinations (grouped by baseline diagnosis). The data is adjusted for age, gender, and education. β-coefficients and p-values are for the statistical effects of hallucinations on CSF α-synuclein in respective diagnostic group (tested by ordinary least square linear regression).